Rosamicin, a macrolide with in vitro activity against Ureaplasma urealyticum.
A new macrolide antibiotic, rosamicin, was shown to have much greater activity in vitro against ureaplasmas isolated from humans than erythromycin or the tetracyclines tested. A marked ureaplasmacidal effect was also shown.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004318:Doxycycline / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D005831:Genital Diseases, Female / Q000382:microbiology; D006801:Humans; D007933:Leucomycins / Q000494:pharmacology*; D008911:Minocycline / Q000494:pharmacology; D013997:Time Factors; D014509:Ureaplasma / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D007933:Leucomycins; D004917:Erythromycin; D008911:Minocycline; D004318:Doxycycline